The potential significance of hepcidin evaluation in progressive supranuclear palsy
Brain and Behavior · 2024-06 · 14 (6)
DOI: 10.1002/brb3.3552 ↗At a glance
Journal article in Brain and Behavior, published online on 2024-06-21. Written by Piotr Alster and 4 co-authors. Institution: Department of Neurology, Medical University of Warsaw, Warsaw, Poland. Major MEDLINE topics: Hepcidins, Supranuclear Palsy, Progressive. Cited 13 times so far (Crossref); 18 references. The full text is freely available (open access, CC BY 4.0). Funded by: Warszawski Uniwersytet Medyczny.
Abstract (original language)
Introduction
Hepcidin is a peptide associated with controlling the distribution of iron in tissues. Growing interest is linked with its impact on neurodegenerative diseases, as disruption of the iron regulation may be considered an initiatory element of pathological protein accumulation. The possible impact of hepcidin was not previously sufficiently explored in progressive supranuclear palsy (PSP).
Methods
Twelve patients with PSP–Richardson's syndrome (PSP–RS), 12 with PSP‐Parkinsonism Predominant (PSP‐P), and 12 controls were examined using Unified Parkinson's Disease Rating Scale—III part (UPDRS‐III) in OFF stage and analyzed in the context of hepcidin levels in the serum.
Results
The work revealed increased levels of hepcidin in PSP–RS when compared to PSP‐P and controls. Moreover, hepcidin was found to be negatively correlated with UPDRS‐III results in PSP–RS, whereas positively in PSP‐P.
Conclusion
The work may suggest a possible impact of hepcidin in PSP, possibly differing depending on its subtype.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
- Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland.
- Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, Warsaw, Poland.
ORCID profiles: Piotr Alster
Funding
- Warszawski Uniwersytet Medyczny
Cite
APA
Alster, P., Otto-Ślusarczyk, D., Wiercińska-Drapało, A., Struga, M., & Madetko-Alster, N. (2024). The potential significance of hepcidin evaluation in progressive supranuclear palsy. Brain and Behavior, 14(6). https://doi.org/10.1002/brb3.3552
Vancouver
Alster P, Otto-Ślusarczyk D, Wiercińska-Drapało A, Struga M, Madetko-Alster N. The potential significance of hepcidin evaluation in progressive supranuclear palsy. Brain and Behavior. 2024;14(6). doi:10.1002/brb3.3552
BibTeX
@article{Alster2024,
author = {Alster, Piotr and Otto-Ślusarczyk, Dagmara and Wiercińska-Drapało, Alicja and Struga, Marta and Madetko-Alster, Natalia},
title = {The potential significance of hepcidin evaluation in progressive supranuclear palsy},
journal = {Brain and Behavior},
year = {2024},
volume = {14},
number = {6},
doi = {10.1002/brb3.3552}
}
EUVIMED